Probity Advisors’s Medtronic MDT Stock Holding History

Probity Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.15M	Sell	13,252 -163	-1%	-$15.6K	0.18%	91
2025 Q4	$1.29M	Sell	13,415 -762	-5%	-$74K	0.21%	82
2025 Q3	$1.35M	Buy	14,177 +373	+3%	+$34.3K	0.22%	78
2025 Q2	$1.2M	Buy	13,804 +4,179	+43%	+$354K	0.21%	82
2025 Q1	$865K	Buy	9,625 +910	+10%	+$81.4K	0.17%	102
2024 Q4	$696K	Buy	8,715 +804	+10%	+$69.6K	0.13%	114
2024 Q3	$712K	Buy	7,911 +718	+10%	+$60.4K	0.14%	118
2024 Q2	$566K	Buy	7,193 +2,544	+55%	+$209K	0.12%	133
2024 Q1	$405K	Buy	4,649 +125	+3%	+$10.7K	0.08%	161
2023 Q4	$373K	Buy	+4,524	New	+$345K	0.08%	161
2023 Q3	–	Sell	-2,383	Closed	-$210K	–	186
2023 Q2	$210K	Buy	+2,383	New	+$205K	0.05%	184

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Probity Advisors's MDT Position: Q1 2026 in Review

Probity Advisors reduced its Medtronic (MDT) stake by 1.2% in Q1 2026, selling an estimated $15.6K and leaving 13,252 shares worth $1.15M. The position accounts for 0.18% of the portfolio, ranked #91.

Probity Advisors first reported a position in MDT in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.35M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Probity Advisors held 13,252 shares of Medtronic worth $1.15M as of Q1 2026.
Probity Advisors sold 163 Medtronic shares in Q1 2026, an estimated $15.6K.
Medtronic made up 0.18% of Probity Advisors's portfolio in Q1 2026, its #91 holding.
Probity Advisors first reported a position in Medtronic in Q2 2023 and has held it in 11 quarters since.
Probity Advisors's Medtronic position peaked at $1.35M in Q3 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Probity Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.